Furoxans (1,2,5-Oxadiazole-N-Oxides) as Novel NO Mimetic Neuroprotective and Procognitive Agents
- 19 March 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (7) , 3076-3087
Abstract
Furoxans (1,2,5-oxadiazole-N-oxides) are thiol-bioactivated NO-mimetics that have not hitherto been studied in the CNS. Incorporation of varied substituents adjacent to the furoxan ring system led to modulation of reactivity toward bioactivation, studied by HPLC-MS/MS analysis of reaction products. Attenuated reactivity unmasked the cytoprotective actions of NO in contrast to the cytotoxic actions of higher NO fluxes reported previously for furoxans. Neuroprotection was observed in primary neuronal cell cultures following oxygen glucose deprivation (OGD). Neuroprotective activity was observed to correlate with thiol-dependent bioactivation to produce NO2–, but not with depletion of free thiol itself. Neuroprotection was abrogated upon cotreatment with a sGC inhibitor, ODQ, thus supporting activation of the NO/sGC/CREB signaling cascade by furoxans. Long-term potentiation (LTP), essential for learning and memory, has been shown to be potentiated by NO signaling, therefore, a peptidomimetic furoxan was tested in hippocampal slices treated with oligomeric amyloid-β peptide (Aβ) and was shown to restore synaptic function. The novel observation of furoxan activity of potential therapeutic use in the CNS warrants further studies.Keywords
This publication has 56 references indexed in Scilit:
- Structure Mechanism Insights and the Role of Nitric Oxide Donation Guide the Development of Oxadiazole-2-Oxides as Therapeutic Agents against SchistosomiasisJournal of Medicinal Chemistry, 2009
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer diseaseProceedings of the National Academy of Sciences, 2009
- Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2008
- Nitric Oxide Donor β2-Agonists: Furoxan Derivatives Containing the Fenoterol Moiety and Related FurazansJournal of Medicinal Chemistry, 2007
- Amyloid-β Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP-Responsive Element-Binding Protein Pathway during Hippocampal Synaptic PlasticityJournal of Neuroscience, 2005
- A New Furoxan NO‐Donor Rabeprazole Derivative and Related CompoundsChemBioChem, 2003
- Inhibition of Caspase-3 by S-Nitrosation and Oxidation Caused by Nitric OxideBiochemical and Biophysical Research Communications, 1997
- No-Mimetic Furoxans: Arylsulphonylfuroxans and Related CompoundsPharmacological Research, 1993
- Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic miceExperimental Neurology, 1986
- Benzofurazans and benzofuroxans: Biochemical and pharmacological propertiesMedicinal Research Reviews, 1981